The five tokens currently tagged under the Binance Labs portfolio span an extraordinary range of market capitalizations, supply dynamics, and price positions relative to their all-time highs. Taken together, they offer a useful lens through which to assess where speculative capital is sitting, where structural risk is building, and which assets are quietly holding ground while others deteriorate.
1. Bitcoin (BTC)
Bitcoin remains the only asset in this group where supply is both fixed and nearly exhausted. With 20.01 million of a maximum 21 million BTC already in circulation, the remaining issuance is negligible in the context of daily volume. That $33.59 billion in 24-hour turnover represents roughly 2.5% of the total market cap changing hands daily, a liquidity profile no other asset on this list comes close to matching.
The 30-day decline of 6.95% is worth comparing against the all-time high of $126,198.07. At $66,804.58, Bitcoin is currently sitting at a 47.06% drawdown from its peak, which in prior cycle terms would place it somewhere in late mid-cycle consolidation territory. The 24-hour and 7-day performances of +0.56% and -1.42%, respectively, signal sideways pressure rather than directional conviction. There are no token unlocks, no inflation mechanism, and no supply overhangs to account for. The only variable is demand.
At roughly half its ATH (all-time high), the risk-to-reward framing depends entirely on macro conditions and cycle timing rather than tokenomics.
2. Ethereum (ETH)
Ethereum is the only asset in this group with no defined maximum supply, a design choice that has become increasingly relevant as its post-Merge issuance dynamics play out. At a circulating supply of 120.69 million ETH and a 24-hour volume of $14.41 billion, liquidity depth is substantial, though noticeably thinner relative to market cap than Bitcoin’s.
The 30-day performance of -0.94% stands out as the most resilient figure across this entire list. While Bitcoin has shed nearly 7% over the same window and other assets have declined far more sharply, Ethereum is essentially flat over a month. The 7-day figure of +0.77% continues that quiet stability. What makes this figure more notable is where it sits relative to its ATH of $4,953.73: a 58.42% drawdown, deeper than Bitcoin’s, yet with substantially less monthly deterioration. Ethereum’s near-zero 30-day movement during a period of broader weakness is a data point worth monitoring. It does not confirm a reversal, but it distinguishes ETH from the risk-off behavior visible elsewhere in this list.
3. Sui (SUI)
Sui holds the largest market capitalization among the three altcoins in this group, but that size comes with a supply structure that deserves close attention. Only 3.95 billion of a maximum of 10 billion SUI are currently circulating, leaving 60.5% of the total supply yet to reach the market. The more consequential figure sits further out: a single cliff-vesting unlock of 5.22 billion tokens, labeled as “allocated release after 2030,” which would represent a 52.17% expansion of circulating supply in a single event. Distant timelines have a way of becoming less distant, and for any position sized beyond a short-term trade, this scheduled supply shock is a number worth keeping on the radar.
SUI’s 7-day decline of 3.97% and 30-day decline of 7.73% place it broadly in line with market-wide selling rather than any asset-specific deterioration. Trading volume tells a more active story: $265.31 million changing hands in 24 hours against a $3.46 billion market cap points to genuine liquidity and consistent speculative interest at current levels.
The ATH context is harder to ignore, however. SUI printed $5.35 at its peak, and the current price of $0.88 sits 83.64% below that mark, a recovery distance that requires either a significant narrative catalyst or a broader bull cycle to close meaningfully. One further note from the metadata: zero audit reports are on record for SUI. That single data point warrants independent verification from any allocator running a formal risk process before committing capital.
The post-2030 unlock is too distant for most trading timeframes but material for long-duration positioning. The absence of audit documentation warrants independent verification before meaningful exposure.
4. Ethena (ENA)
Ethena presents the most complex tokenomic picture in this group. With a 15 billion maximum supply, 8.49 billion ENA is currently circulating. The unlock schedule is active and recurring: multiple linear unlock entries of approximately 171.88 million tokens each are logged, split between private sale investors at 78.13 million per tranche and team, advisors, and contractors at 93.75 million per tranche, with at least 10 scheduled events.
ENA has declined 31% over 30 days and 13.81% over seven days, the worst figures across all five assets in both windows. The ATH of $1.52 against the current price of $0.08 represents a 94.59% drawdown, a level that demands scrutiny. The 24-hour volume of $108.42 million is high relative to market cap, which can indicate speculative activity or sustained distribution depending on directional context. Like Sui, Ethena carries zero audit reports.
The combination of active linear unlocks, a 94.59% ATH drawdown, and the steepest 30-day decline in the group places ENA in a category that requires clear entry rationale.
5. Aptos (APT)
Aptos is the smallest market cap asset in the Binance Labs group at $691.54 million, and, at the time of writing, the 24-hour volume of this digital asset trends at $43.71 million. The circulating supply of 794.3 million APT against a maximum of 2.10 billion means roughly 62% of total supply remains undistributed, though no near-term unlocks are currently flagged in the data.
The 30-day and 7-day performance figures of -15.00% and -13.48% are the second-worst in this group after ENA. What distinguishes APT is the severity of its ATH drawdown: at $0.87 against an ATH of $19.90, the asset is 95.63% below its peak. This is not a rounding difference from Ethena’s 94.59%, but the context matters.
APT’s decline has not been driven by visible recurring unlock pressure at this time, and its MoveVM architecture continues to be developed alongside Sui in the same technical lineage. The 24-hour uptick of +1.09% is the only positive short-term data point, though it is insufficient to draw directional conclusions from. At a $691.54 million market cap with 62% of supply still to enter circulation and a 95.63% ATH drawdown, Aptos is priced as a high-risk, early-stage recovery candidate. Any thesis here rests on adoption and developer activity metrics that fall outside the scope of this data snapshot.
